CMS Will Weigh Three New Tech Assessments On Genetic Testing For Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Two of the assessments are intended to inform an upcoming Medicare Evidence Development and Coverage Advisory Committee meeting.